Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
March 18, 2008

Ingenuity Systems Extends Software Agreement with GSK

  • Ingenuity Systems extended and expanded their existing license agreement with GlaxoSmithKline (GSK) for access to Ingenuity Pathways Analysis (IPA) software. The new deal enables GSK to provide enterprise-wide IPA access to researchers for assessment of the signaling and metabolic pathways, molecular networks, and biological processes involving disease targets. In addition, GSK will also use Ingenuity's content and algorithms.
  • You’re all set! Thank you for subscribing to GEN Highlights.